Prediction of cell kill kinetics of anticancer agents using the collagen gel droplet embedded-culture drug sensitivity test

Oncology Reports

Volumn 9, Issue 2, 2002, Pages 301-305

  Mori, Takeshi ^a   Ohnishi, Masafumi ^a   Komiyama, Megumi ^a   Tsutsui, Arisa ^a   Yabushita, Hiromitsu ^a   Okada, Hiroshi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD DST; Cell kill kinetics test; Gemcitabine; Taxanes; Vinorelbine

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7-ETHYL-10-HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CAMPTOTHECIN; COLLAGEN; DEOXYCYTIDINE; DNA TOPOISOMERASE; DOCETAXEL; DRUG DERIVATIVE; GEMCITABINE; NAVELBINE; PACLITAXEL; RIBONUCLEOTIDE REDUCTASE; TAXOID; VINBLASTINE;

ARTICLE; CELL CULTURE; CELL DEATH; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; HUMAN; METABOLISM;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CELL DEATH; COLLAGEN; COLONIC NEOPLASMS; DEOXYCYTIDINE; DNA TOPOISOMERASES, TYPE I; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PACLITAXEL; RIBONUCLEOTIDE REDUCTASES; TAXOIDS; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0036517735     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.2.301     Document Type: Article

References (35)

1. Wani MC, Taylor HL, Wall ME, Coggon P and McPhail AT: Plant antitumor agents VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
2. Bissery MG, Guenard D, Guertte VF and Lavelle F: Experimental antitumor activity of Taxotere (RP 5697, NSC 628503), a taxol analogue. Cancer Res 51: 4845-4852, 1991.
3. Kunimoto T, Nitta K, Tanaka T, Uehara N, et al: Antitumor activity of 7-ethyl-10-[4-(1-piperidion)-1-piperidino] carbonyloxy-camptothecin, a novel water soluble derivative of camptothecin, against murine tumor. Cancer Res 47: 5944-5947, 1987. (Pubitemid 18018734)
4. Pierre P: The synthesis of navelbine prototype of a new series of vinblastine derivatives. Semin Oncol 16 (Suppl. 4): 2-4, 1989.
5. Plunkett W, Huang P, Searcy CE and Gandhi V: Gemcitabine: preclinical pharmacology and mechanism of action. Semin Oncol 23 (Suppl. 10): 3-15, 1996. (Pubitemid 26362189)
6. Salmon SE, Hamburger AW, Soehnlen B, Durie BG, Alberts DS and Moon TE: Quantitation of differential sensitivity of human tumor stem cells to anticancer drugs. N Engl J Med 298: 1321-1327, 1978. (Pubitemid 8357629)
7. Mosmann T: Rapid calorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
8. Vescino RA, Connors KM, Kubota T and Hoffman RM: Correlation of histology and drug response of human tumor grown in nude mice. Proc Natl Acad Sci USA 88: 5163-5166, 1991.
9. Furukawa T, Kubota T, Watanabe M, et al: High in vitro-in vivo correlation of drug response using sponge gel-supported three-dimensional histoculture and the MTT end point. Int J Cancer 51: 489-498, 1992.
10. Yang J, Richards J, Bowman P, et al: Sustained growth and three-dimensional organization of primary mammary tumor epithelial cells embedded in collagen gels. Proc Natl Acad Sci USA 76: 3401-3405, 1979. (Pubitemid 9233969)
11. Kobayashi H, Tanisaka K, Doi O, et al: An in vitro chemosensitivity test for human tumors using collagen gel droplet embedded cultures. Int J Oncol 11: 449-455, 1997. (Pubitemid 27364274)
12. Inaba M, Tashiro T, Sato S, Ohnishi Y, Tanisaka K, Kobayashi H and Koezuka M: In vitro-in vivo correlation in anticancer drug sensitivity test using AUC-based concentrations and collagen gel droplet-embedded culture. Oncology 53: 250-257, 1996. (Pubitemid 26131951)
13. Araki Y, Isomoto H, Matsumoto A, et al: An in vitro chemosensitivity test for colorectal cancer using collagen-gel droplet embedded cultures. Kurume Med J 46: 163-166, 1999. (Pubitemid 30079753)
14. Yasuda K, Takada T, Wada K, et al: A new in vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility. J Hematol Pancre Surg 5: 261-268, 1998. (Pubitemid 128662591)
15. Kobayashi H, Higashiyama M, Minamigawa K, et al: Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric end point quantification. Jpn J Cancer Res 92: 1-8, 2001.
16. Fruehauf JP, Myers CE and Sinha BK: Synergistic activity of suramin with tumor necrosis factor alpha and doxorubicin on human prostate cancer cell lines. J Natl Cancer Inst 82: 1206-1209, 1990. (Pubitemid 20219497)
17. Tanigawa N, Kern DH, Hisaka Y and Morton DL: Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res 42: 2159-2164, 1982. (Pubitemid 12121424)
18. Kern DH, Drogemullar CR, Kennedy MC, et al: Development of miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res 45: 5436-5441, 1985. (Pubitemid 16200800)
19. Kondo T, Imamura T and Ichihashi H: In vitro test for sensitivity of tumor to carcinostatic agents. Jpn J Cancer Res 57: 113-121, 1966.
20. Shoemaker R, Wolpert DM, Kern DH, et al: Application of a human tumor colony-forming assay to new drug screening. Cancer Res 45: 2145-2153, 1985. (Pubitemid 15024321)
21. Yang J and Nandi S: Growth of cultured cells using collagen as substrate. Int Rev Cytol 81: 249-286, 1983. (Pubitemid 13078151)
22. Tamura T, Sasaki Y, Eguchi K, et al: Phase I and pharmacokinetics study of paclitaxel by 24-hour intravenous infusion. Jpn J Cancer Res 85: 1057-1062, 1994. (Pubitemid 24325029)
23. Kouroussis C, Agelaki S, Mavroudis D, et al: A dose escalation study of weekly docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol 46: 488-492, 2000.
24. Rothenberg ML, Kuhn JG, Burris HA, et al: Phase I and pharmacokinetics trial of weekly CPT-11. J Clin Oncol 11: 2194-2204, 1993.
25. Delord JP, Raymond E, Chaouche M, et al: A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies. Ann Oncol 11: 73-79, 2000. (Pubitemid 30084583)
26. Shimoyama M: Cytocidal action of anticancer antigens: evaluation of the sensitivity of cultured animal and human cancer cells. Bibl Haematologica 40: 711-722, 1975.
27. Taguchi T, Kose K, Fukuoka M, et al: LY188011 phase I study, Research group of Gemcitabine (LY188011). Gan to Kaaaku Ryoho (in Japanese) 23: 1011-1018, 1996.
28. Gianni L, Kearns CM, Giani A, et al: Non-linear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetics/pharmacodynamic relationships in humans. J Clin Oncol 13: 180-190, 1995.
29. Klaassen U, Wilke H, Strumberg D, Eberhardt W, Korn M and Seeber S: Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer. Eur J Cancer 32A: 547-549, 1996.
30. Seidman AD, Hudis CA, Albanel J, et al: Dose-dense therapy with weekly 1-hour paclitaxel infusion in the treatment of metastatic breast cancer. J Clin Oncol 16: 3353-3361, 1998. (Pubitemid 28481632)
31. Extra JM, Rousseau F, Bruno R, Clavel M, LeBail N and Marty M: Phase I and pharmacokinetics study of taxotere (RP56976; NSC628503) given as a short intravenous infusion. Cancer Res 53: 1037-1042, 1993. (Pubitemid 23087904)
32. Kawato Y, Aonuma M, Hirota Y, Kuga H and Sato K: Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res 51: 4187-4194, 1991.
33. Skipper HE, Schable FM, Mellett LB, Montgomery JA, Wilkoff LJ, Lloyd HH and Brockman RW: Implications of biochemical, cytokinetic, pharmacologic relationship in the design of optimal therapeutic schedules. Cancer Chemother Rep 54: 431-450, 1970.
34. Rahmani R, Bruno R, Iliadis A, Favre R, Just S, Barbet J and Cano JP: Clinical pharmacokinetics of the antitumor drug navelbine (5′- noranhydrovinblastine). Cancer Res 47: 5796-5799, 1987. (Pubitemid 18046783)
35. Heinemann V, Hertel LW, Grindey GB and Plunkett W: Comparison of the cellular pharmacokinetics and toxicity of 2′,2′- difluorodeoxycytidine and 1-β-D-arabinofuranosylcytosine. Cancer Res 48: 4024-4031, 1988.